Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy
Clinical trial NCT02886728 · COMPLETED
Trial details
- NCT number
- NCT02886728
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-08
- Primary completion
- 2018-10-05
- Enrollment
- 1252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.